This comprehensive review examines the expanding therapeutic potential of heparin derivatives in oncology, extending beyond traditional anticoagulation mechanisms to include direct antineoplastic effects, heparanase inhibition, and modulation of tumor microenvironment interactions. This evidence concerns the gene HPSE and neoplasm.